ArticleProceedings of the National Academy of Sciences of the United States of America2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.
Adrian Gervais et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.